Core Viewpoint - An investigation is underway regarding potential breaches of fiduciary duties by the Board of Directors of Warner Bros. Discovery, Inc. in relation to the proposed sale of the Company or its parts [1][3]. Group 1: Investigation Details - The investigation is being conducted by Berger Montague PC, focusing on whether the Board failed to maximize shareholder value during the sales process [3]. - The inquiry will assess if the Board adequately evaluated acquisition proposals for the Company or its divisions [3]. Group 2: Company Overview - Warner Bros. Discovery, Inc. is a multinational mass-media and entertainment conglomerate, involved in film and TV studios, streaming services, and cable/linear networks [2]. - The Company is headquartered in New York City [2]. Group 3: Law Firm Background - Berger Montague is a prominent law firm specializing in complex civil litigation, class actions, and mass torts, with over $2.4 billion in post-trial judgments in 2025 [4]. - The firm has recovered over $50 billion for its clients over its 55-year history [4].

MoonLake, based in Zug, Switzerland, is a clinical-stage biotech firm focused on advancing next-generation immunotherapies. PHILADELPHIA, Dec. 11, 2025 /PRNewswire/ -- National plaintiffs' law firm Berger Montague PC announces a class action lawsuit against MoonLake Immunotherapeutics (NASDAQ: MLTX) ("MoonLake" or the "Company") on behalf of investors who purchased MoonLake shares during the period of March 10, 2024 through September 29, 2025 (the "Class Period"). Investor Deadline: Investors who purchased ...

PHILADELPHIA, Dec. 10, 2025 /PRNewswire/ -- National plaintiffs' law firm Berger Montague PC announces that a class action lawsuit has been filed against Jayud Global Logistics Limited (NASDAQ: JYD) ("Jayud" or the "Company") on behalf of investors who purchased or otherwise acquired Jayud securities during the period of April 21, 2023 through April 30, 2025 (the "Class Period"), inclusive. Investor Deadline: Investors who purchased Jayud securities during the Class Period may, no later than January 20, 20 ...

PHILADELPHIA, Dec. 10, 2025 (GLOBE NEWSWIRE) -- National plaintiffs’ law firm Berger Montague PC announces that a class action lawsuit has been filed against Stride, Inc. (NYSE: LRN) (“Stride” or the “Company”) on behalf of investors who purchased Stride securities during the period of October 22, 2024 through October 28, 2025 (the “Class Period”). Investor Deadline: Investors who purchased Stride securities during the Class Period may, no later than January 12, 2026, seek to be appointed as a lead plaintif ...

PHILADELPHIA, Dec. 9, 2025 /PRNewswire/ -- National plaintiffs' law firm Berger Montague PC announces that a class action lawsuit has been filed against Telix Pharmaceuticals Ltd. (NASDAQ: TLX) ("Telix" or the "Company") on behalf of investors who purchased Telix securities during the period of February 21, 2025 through August 28, 2025 (the "Class Period"). Investor Deadline: Investors who purchased Telix securities during the Class Period may, no later than January 9, 2026, seek to be appointed as a lead ...

PHILADELPHIA, Dec. 09, 2025 (GLOBE NEWSWIRE) -- National plaintiffs’ law firm Berger Montague PC announces a class action lawsuit has been filed against Fiserv, Inc. (NASDAQ: FISV) (NYSE: FI) (“Fiserv” or the “Company”) on behalf of investors who purchased Fiserv shares during the period of July 23, 2025 through October 29, 2025 (the “Class Period”). Investor Deadline: Investors who purchased Fiserv securities during the Class Period may, no later than January 5, 2026, seek to be appointed as a lead plainti ...

PHILADELPHIA, Dec. 8, 2025 /PRNewswire/ -- National plaintiffs' law firm Berger Montague PC announces a class action lawsuit against James Hardie Industries plc (NYSE: JHX) ("James Hardie" or the "Company") on behalf of investors who purchased James Hardie common stock or American Depositary Shares during the period of May 20, 2025 through August 18, 2025 (the "Class Period"). Investor Deadline: Investors who purchased James Hardie securities during the Class Period may, no later than December 23, 2025, se ...

PHILADELPHIA, Dec. 8, 2025 /PRNewswire/ -- National plaintiffs' law firm Berger Montague PC announces that a class action lawsuit has been filed against StubHub Holdings, Inc. (NYSE: STUB) ("StubHub" or the "Company") on behalf of investors who purchased or otherwise acquired StubHub securities during the period of September 14, 2025 through November 24, 2025 (the "Class Period"), including shares issued pursuant and/or traceable to StubHub's September 2025 initial public offering ("IPO"). Investor Deadlin ...

Core Viewpoint - A class action lawsuit has been filed against Skye Bioscience, Inc. for allegedly misleading investors regarding the efficacy of its lead product candidate, nimacimab, during the class period from November 4, 2024, to October 3, 2025 [1] Company Overview - Skye Bioscience, Inc. is a clinical-stage biotechnology company based in San Diego, focusing on developing treatments for obesity and metabolic diseases [1] Legal Proceedings - The lawsuit claims that Skye failed to disclose that the efficacy of nimacimab was lower than represented, leading to an overstatement of the drug's clinical and commercial potential [1] - Investors who purchased Skye securities during the class period have until January 16, 2026, to seek appointment as lead plaintiff [1] Stock Performance - Following the announcement of topline data from a Phase 2a study on October 6, 2025, which revealed that the primary endpoint of an 8% weight loss difference compared to placebo was not met, Skye's stock price fell by $2.85 per share, or 60%, closing at $1.90 [1]

Core Viewpoint - A class action lawsuit has been filed against Six Flags Entertainment Corp. on behalf of investors who acquired shares during the period from July 1, 2024, to November 5, 2025, particularly related to the merger with Cedar Fair L.P. [1][3] Summary by Sections Lawsuit Details - The lawsuit claims that the merger registration statement and prospectus did not accurately reflect Six Flags' financial and operational status, highlighting years of underinvestment that necessitated significant capital for the parks to remain competitive [3] Stock Performance - Following the merger closing on July 1, 2024, Six Flags' stock price fell from above $55 per share to as low as $20, representing a 64% decline in value [4] Investor Information - Investors who purchased Six Flags securities during the class period have until January 5, 2026, to seek appointment as lead plaintiff representatives [2]